
Article 1 
The position to be adopted on the Union's behalf by the Member States in the Commission on Narcotic Drugs on 13 to 17 March 2017, when that body is called upon to adopt decisions on the addition of substances to the Schedules of the United Nations Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol and the United Nations Convention on Psychotropic Substances of 1971 at its 60th session, shall be in accordance with the Annex to this Decision.
The position shall be expressed by the Member States that are members of the Commission on Narcotic Drugs, acting jointly in the interest of the Union.
Article 2 
This Decision is addressed to the Member States in accordance with the Treaties.
Done at Brussels, 7 March 2017.
For the Council
The President
L. GRECH
ANNEX

Position to be taken by the Member States which are members of the Commission on Narcotic Drugs acting jointly in the interest of the Union during the 60th session of the Commission on Narcotic Drugs on 13 to 17 March 2017 regarding changes in the scope of control of substances:

((1)) U-47700 is to be included in Schedule I of the Single Convention of Narcotic Drugs of 1961 as amended by the 1972 Protocol.
((2)) Butyrfentanyl is to be included in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol.
((3)) 4-MEC (4-methylethcathinone) is to be included in Schedule II of 1971 Convention on Psychotropic Substances.
((4)) Ethylone is to be included in Schedule II of the Convention on Psychotropic Substances of 1971.
((5)) Pentedrone (α-methylaminovalerophenone) is to be included in Schedule II of the Convention on Psychotropic Substances of 1971.
((6)) Ethylphenidate (EPH) is to be included in Schedule II of the Convention on Psychotropic Substances of 1971.
((7)) MPA (methiopropamine) is to be included in Schedule II of the Convention on Psychotropic Substances of 1971.
((8)) MDMB-CHMICA is to be included in Schedule II of the Convention on Psychotropic Substances of 1971.
((9)) 5F-APINACA (5F-AKB48) is to be included in Schedule II of the Convention on Psychotropic Substances of 1971.
((10)) XLR-11 is to be included in Schedule II of the Convention on Psychotropic Substances of 1971.
